What laboratory tests should be ordered for a 49-year-old perimenopausal woman presenting with low libido?

Laboratory Testing for Low Libido in Perimenopausal Women

Routine laboratory testing for low libido in perimenopausal women should be limited to thyroid function tests and, if clinically indicated to confirm menopausal status, FSH and estradiol levels—testosterone and other androgen measurements are not recommended for routine assessment of sexual dysfunction.

Diagnostic Approach

The diagnosis of low libido (hypoactive sexual desire disorder) in perimenopausal women is fundamentally clinical, not laboratory-based 1. The Endocrine Society guidelines emphasize that menopause diagnosis relies on clinical criteria—specifically menstrual patterns—and laboratory testing is only suggested when establishing menopausal status is necessary for management decisions 1.

When to Order Labs

For confirming menopausal status (when clinically unclear):

• FSH (replicate measures)
• Serum estradiol (replicate measures, looking for levels <20 pg/mL)
• These should be obtained on multiple occasions to account for hormonal fluctuations 1

For excluding other causes of sexual dysfunction:

• Thyroid function tests (TSH, free T4) - The guidelines specifically mention thyroid hormone excess as a differential diagnosis for menopausal symptoms 1
• Consider prolactin if galactorrhea is present 2

What NOT to Order Routinely

Testosterone and androgen testing should NOT be part of routine clinical assessment for perimenopausal women presenting with low libido 3. Here's why:

• The most recent high-quality evidence (2026) from the Australian Women's Midlife Years Study found no association between testosterone, DHEA, or androstenedione and sexual desire in perimenopausal women 3
• A 2025 study of premenopausal women confirmed that testosterone and pre-androgen profiles do not clearly identify women with low sexual arousal and desire 4
• A 2016 systematic review concluded that available evidence does not support testosterone serum evaluation in premenopausal women with low libido 5

Important Nuances and Caveats

The Androgen Therapy Exception

While routine testosterone testing is not recommended, there is a specific exception for postmenopausal women with hypoactive sexual desire disorder (HSDD) who are being considered for androgen therapy 6. The 2014 Endocrine Society guideline on androgen therapy notes that:

• Transdermal testosterone (300 µg/d) has shown efficacy in surgically and naturally menopausal women with HSDD
• Benefits include increased satisfying sexual events (median increase of 1 event per month) and decreased personal distress 6
• However, this applies primarily to postmenopausal women, not perimenopausal women

Clinical Assessment Takes Priority

The key factors associated with decreased libido in perimenopausal women are:

• Depression (OR 3.4) 7
• Vaginal dryness (OR 3.5) 7
• Psychosocial factors (children at home, relationship status) 7
• Interestingly, testosterone fluctuation (not absolute levels) was associated with decreased libido 7

Common Pitfalls to Avoid

1. Don't order testosterone levels reflexively - The evidence consistently shows no correlation with desire in perimenopausal women 3, 5, 4

2. Don't rely on single hormone measurements - If you do need to confirm menopausal status, FSH and estradiol fluctuate significantly and require replicate measures 1

3. Don't overlook thyroid dysfunction - This is specifically mentioned in guidelines as a differential diagnosis and is a treatable cause of sexual dysfunction 1

4. Don't ignore the clinical context - Moderate-to-severe depressive symptoms, vaginal dryness, and relationship factors are more predictive than hormone levels 3, 7

Practical Algorithm

For a 49-year-old perimenopausal woman with low libido:

1. First-line assessment: Clinical history focusing on:

   • Menstrual pattern changes
   • Presence of vasomotor symptoms
   • Vaginal dryness
   • Mood symptoms/depression
   • Relationship factors
   • Medications (especially oral contraceptives, oral estrogens, glucocorticoids)

2. Laboratory testing:

   • TSH and free T4 (to exclude thyroid dysfunction)
   • If menopausal status unclear and impacts management: FSH and estradiol (replicate measures)

3. Do NOT order: Testosterone, DHEA, androstenedione, or other androgens

4. Address modifiable factors: Treat depression, manage vaginal dryness, consider menopausal hormone therapy if appropriate based on symptom profile and risk factors 1